SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

JP Morgan Maintains Neutral on Cardlytics, Raises Price Target to $130

JP Morgan analyst Doug Anmuth maintains Cardlytics (NASDAQ:CDLX) with a Neutral and raises the price target from $110 to $130.

· 03/16/2021 08:46
JP Morgan analyst Doug Anmuth maintains Cardlytics (NASDAQ:CDLX) with a Neutral and raises the price target from $110 to $130.